Generate Biomedicines, Inc. (GENB)
16.39
+0.05
(+0.31%)
USD |
NASDAQ |
Sep 04, 16:00
16.37
-0.02
(-0.12%)
After-Hours: 20:00
Generate Biomedicines SG&A Expense (TTM) : 27.12M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 27.12M |
| March 31, 2026 | 13.52M |
| Date | Value |
|---|---|
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Twist Bioscience Corp. | 290.29M |
| Intellia Therapeutics, Inc. | 136.25M |
| Prime Medicine, Inc. | 54.39M |
| Moderna, Inc. | 965.00M |
| Beam Therapeutics, Inc. | 125.40M |